Khattar Jack A.
CEO
Latest Insider Transactions
Showing 10 of 66 transactions (past 365 days)
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Sale | 120 | $51.75 | $6,210 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Sale | 24,138 | $50.09 | $1,209,072 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Other | 12,500 | $0.00 | $0 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Other | 12,500 | $0.00 | $0 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Sale | 10,742 | $51.00 | $547,842 |
| 2026-03-10 | 2026-03-06 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Exercise Conversion | 38,640 | $0.00 | $0 |
| 2026-03-10 | 2026-03-06 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Tax Payment | 16,574 | $54.73 | $907,095 |
| 2026-02-20 | 2026-02-18 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Award | 341,610 | $0.00 | $0 |
| 2025-10-10 | 2025-10-09 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Sale | 58,371 | $50.55 | -$2,950,654 |
| 2025-10-10 | 2025-10-09 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Exercise Conversion | 81,250 | $25.30 | $2,055,625 |
SUPN
CEO
Sale
$1.2M
24,138 shares @ $50.09
Filed 2026-03-16Trade 2026-03-13
Supernus Pharmaceuticals, Inc.SUPN
CEO
Sale
$547.8K
10,742 shares @ $51.00
Filed 2026-03-16Trade 2026-03-13
Supernus Pharmaceuticals, Inc.SUPN
CEO
Exercise Conversion
$0
38,640 shares @ $0.00
Filed 2026-03-10Trade 2026-03-06
Supernus Pharmaceuticals, Inc.SUPN
CEO
Tax Payment
$907.1K
16,574 shares @ $54.73
Filed 2026-03-10Trade 2026-03-06
Supernus Pharmaceuticals, Inc.SUPN
CEO
Exercise Conversion
$2.1M
81,250 shares @ $25.30
Filed 2025-10-10Trade 2025-10-09
Supernus Pharmaceuticals, Inc.Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.